SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.310
-0.130 (-2.93%)
At close: Oct 17, 2025, 4:00 PM EDT
4.400
+0.090 (2.09%)
After-hours: Oct 17, 2025, 5:31 PM EDT
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $291.27 million as of October 17, 2025. Its market cap has increased by 24.62% in one year.
Market Cap
291.27M
Enterprise Value
260.26M
1-Year Change
24.62%
Ranking
Category
Stock Price
$4.31
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $291.27M, a decrease of -74.00%. That is a compound annual growth rate of -27.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 291.27M | 42.80% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |